
NASDAQHealthcareMedical - Specialties
最新資料
US$3.13
−US$0.08 · -2.49%
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
前收盤價
US$3.13
−US$0.08 · -2.49%
盤中時間採用ET。市場資料可能有所延遲。
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
日內區間
目前US$3.13
52週區間
目前US$3.13
盤中時間採用ET。市場資料可能有所延遲。
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
日內區間
目前US$3.13
52週區間
目前US$3.13
近期已公布業績
近期已公布業績
AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。